title: In situ oxygen utilization in the rat intervertebral disc.
abstract: Nucleus pulposus cells of the intervertebral disc have no endogenous vasculature and have thus been hypothesized to be hypoxic. This hypothesis was tested using 2-nitroimidazole, EF5, a drug that at low oxygen concentrations forms covalent adducts with cellular proteins. After administrating EF5 to rats, sections of the intervertebral disc were analysed for EF5 adducts. Drug adducts were quantified in tissue sections using a fluorescent monoclonal antibody. Although the level of EF5 fluorescence in all intervertebral disc tissues was low, the transition zone at the periphery of the nucleus pulposus exhibited the highest level of EF5 binding. To substantiate this result, tissue nitroreductase levels and drug pharmacology were evaluated. Nitroreductase levels were measured in whole discs under severe hypoxia. We noted that there was robust EF5 binding to cells in the annulus fibrosus and transition zone with modest binding to cells of the nucleus pulposus and endplate. High-performance liquid chromatography analysis indicated limitations in EF5 access to the nucleus pulposus, most probably related to the lack of vasculature and slow drug distribution through the gel-like interior of the disc. However, despite diffusion problems, the drug dose was determined to be sufficient to report the oxygen status of the nucleus pulposus cells. Based on these findings, we conclude that despite poor vascularization, the disc cells accommodate to the local environment by displaying a limited need for oxygen. Accordingly, the cells of the intervertebral disc are not severely hypoxic.
authors.affiliation: Department of Orthopedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA.
authors.forename: Deanna C
authors.initials: DC
authors.lastname: Lee
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Adams
authors.forename: Todd J
authors.initials: TJ
authors.lastname: Albert
authors.forename: Irving M
authors.initials: IM
authors.lastname: Shapiro
authors.forename: Sydney M
authors.initials: SM
authors.lastname: Evans
authors.forename: Cameron J
authors.initials: CJ
authors.lastname: Koch
mesh_terms: D000818:Animals; D017341:Etanidazole / Q000031:analogs & derivatives* / Q000032:analysis / Q000378:metabolism; D006845:Hydrocarbons, Fluorinated / Q000032:analysis / Q000378:metabolism*; D007150:Immunohistochemistry; D007202:Indicators and Reagents / Q000032:analysis / Q000378:metabolism*; D007403:Intervertebral Disc / Q000737:chemistry / Q000378:metabolism*; D008297:Male; D009601:Nitroreductases / Q000032:analysis / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D017208:Rats, Wistar; D005466:Fluorocarbons
chemical_list: D017341:Etanidazole; D006845:Hydrocarbons, Fluorinated; D007202:Indicators and Reagents; D009601:Nitroreductases; D010100:Oxygen; C096011:2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide; D005466:Fluorocarbons